Montelukast Tablet, Film Coated
Product Images NDC 0781-5560

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 0781-5560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Montelukast 01

This appears to be a graph or chart displaying the change in height (in centimeters) over the course of treatment, with weeks on the horizontal axis. However, it is difficult to understand the exact details without additional context or a clearer image. The text "Ghlosnuraay" and other random characters do not provide any useful information.*

FDA Label Image

Montelukast 02

FDA Label Image

Montelukast 03

This is a chart displaying the mean percent change from baseline at 15 weeks in treatment with either placebo or Montelukast. The chart shows that Montelukast had a positive percent change while the placebo had no change. The treatment period lasted for 15 weeks with a washout period in between.*

FDA Label Image

Montelukast 04

This is a description of Montelukast Sodium Chewable tablets with NDC 0781-5555-31. It is a prescription drug used for pediatric patients aged from 6 to 14 years. The tablets contain 5.2mg montelukast sodium equivalent to 5mg montelukast. Phenylketonurics contains 0.6mg aspartame component per 5mg chewable tablet. The recommended dosage is indicated on the accompanying circular. It should be stored in a tight container, protected from moisture and light, between 20°C and 25°C. The drug is manufactured by Sandoz Private Ltd. in India and is for Sandoz Inc., Princeton, NJ. Code No.: MH/DRUGS/KD-548 Rev. 10/2016 46137039.*

FDA Label Image

Montelukast 05

This is a prescription drug called Montelukast Sodium in tablet form, manufactured by Sandoz Private Ltd in India for Sandoz Inc. Each tablet contains 10.4 mg of montelukast sodium, equivalent to 10 mg montelukast. This drug is intended for adults who are 15 years or older. The usual dosage information is included in the package insert. To maintain the quality of the drug, the tablet should be stored at 20° to 25°C and protected from moisture and light. It should be dispensed in an original, light-resistant container. The code number for the drug is MH / DRUGS / KD-548 Rev. 11/2016 46137041.*

FDA Label Image

Montelukast 06

This is a medication called Montelukast Sodium that comes in chewable tablet form. It is intended for pediatric patients who are between 2 to 5 years of age and is only available through a prescription. Each tablet contains 4.2mg of montelukast sodium which is equivalent to 4mg of the medication. The recommended dosage can be found in the accompanying circular. This medication should be stored at 20°C to 25°C (68°F to 77°F) and protected from moisture and light. It is manufactured in India by Sandoz Private Limited and distributed by Sandoz Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.